By dividing all patients into high and low expression group with the median value of SRRM2-AS1 as a cutoff value, we found high level of SRRM2-AS1 was significantly associated with tumor size, lymph node metastasis and TNM stage (Table 3). Here, SRRM2 is linked to neoplasm.